Skip to content

Iclaprim

ANTIINFECTIVES FOR SYSTEMIC USE

Also known as: iclaprim mesilate, iclaprim mesylate

ATC J01EA03

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Iclaprim is a drug catalogued in DrugCentral. DrugCentral lists 5 molecular targets, including folA, folA and dfrA17.

  • Molecular targets: folA, folA, dfrA17 and DHFR (5 listed in DrugCentral).
  • ATC code: J01EA03 (Trimethoprim and derivatives).
  • Molecular formula: C19H22N4O3; molecular weight 354.41 g/mol.

Mechanism & targets

Molecular targets (5)

TargetGeneActionActivity
Dihydrofolate reductasefolAunknownKi 10.10
Dihydrofolate reductasefolAunknownIC50 8.15
Dihydrofolate reductasedfrA17unknownIC50 8.15
Dihydrofolate reductaseDHFRunknownKi 6.11
Dihydrofolate reductase—unknownIC50 5.62

ATC classification

ATC codeTherapeutic hierarchy
J01EA03ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › SULFONAMIDES AND TRIMETHOPRIM › Trimethoprim and derivatives

Chemical structure

Molecular formulaC19H22N4O3
Molecular weight354.41 g/mol
CAS number192314-93-5
InChIKeyHWJPWWYTGBZDEG-UHFFFAOYSA-N
PubChem CID213043
COC1=CC(CC2=CN=C(N)N=C2N)=C2C=CC(OC2=C1OC)C1CC1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Iclaprim work?

Its molecular targets in DrugCentral include folA, folA, dfrA17 and DHFR.

What is the chemical formula of Iclaprim?

Iclaprim has the molecular formula C19H22N4O3 and a molecular weight of 354.41 g/mol.

Browse: all drugs starting with I · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets5
Indications0
FormulaC19H22N4O3
DrugCentral ID4573
Interactive profile